9877 — Jenscare Scientific Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.81bn
- HK$974.60m
- 18
- 15
- 65
- 20
Annual cashflow statement for Jenscare Scientific Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -300 | -501 | -441 | -379 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 251 | 366 | 267 | 184 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.75 | -12.1 | 6.64 | -39.5 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -46.9 | -142 | -158 | -222 |
| Capital Expenditures | -2.57 | -15.4 | -49.6 | -78.6 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 9.19 | -460 | -97 | 437 |
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 6.62 | -475 | -147 | 358 |
| Financing Cash Flow Items | -13.3 | -0.373 | 191 | 23.9 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 384 | 1,075 | 189 | 56.4 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 343 | 452 | -73.2 | 200 |